Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_assertion type Assertion NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_head.
- NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_provenance.
- NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_assertion evidence source_evidence_literature NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_provenance.
- NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_assertion SIO_000772 16682723 NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_provenance.
- NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_assertion wasDerivedFrom befree-20140225 NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_provenance.
- NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_assertion wasGeneratedBy ECO_0000203 NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_provenance.